U.S. Markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
176.80-2.37 (-1.32%)
At close: 4:00PM EDT

176.25 -0.55 (-0.31%)
After hours: 7:30PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close179.17
Open180.00
Bid176.52 x 1100
Ask181.00 x 800
Day's Range176.28 - 181.46
52 Week Range101.81 - 181.46
Volume490,079
Avg. Volume742,491
Market Cap10.058B
Beta (5Y Monthly)1.06
PE Ratio (TTM)41.90
EPS (TTM)4.22
Earnings DateAug 02, 2021 - Aug 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est203.06
  • Jazz Pharmaceuticals Has a Good Gig Going
    TheStreet.com

    Jazz Pharmaceuticals Has a Good Gig Going

    In the updated daily bar chart of JAZZ, below, we can see that our trade recommendation in August worked out nicely with our $173 price target getting reached in January. The On-Balance-Volume (OBV) line was steady from November to April but now looks like it is restarting its uptrend as traders are being more aggressive buyers. In the weekly bar chart of JAZZ, below, we went back four years to see if there was a lot of chart resistance around $180.

  • 10 Best Weed Stocks to Buy Now
    Insider Monkey

    10 Best Weed Stocks to Buy Now

    In this article, we will take a look at the 10 best weed stocks to buy now. You can skip our comprehensive analysis of the cannabis industry and go directly to the 5 Best Weed Stocks to Buy Now. While the coronavirus pandemic has wreaked havoc on many industries around the world, the weed industry proved […]

  • Analysts Just Shipped A Captivating Upgrade To Their Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Estimates
    Simply Wall St.

    Analysts Just Shipped A Captivating Upgrade To Their Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Estimates

    Jazz Pharmaceuticals plc ( NASDAQ:JAZZ ) shareholders will have a reason to smile today, with the analysts making...